European researchers in limbo waiting for EU’s decision on whether CRISPR plants are GMOs

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Plant geneticist Stefan Jansson is champing at the bit to start field trials on crops tweaked with powerful gene-editing technologies. He plans to begin by using edits to study how the cress plantย Arabidopsisย protects its photosynthetic machinery from damage in excessively bright light.

But the future of his work depends on the European Commissionโ€™s answer to a legal conundrum. Should it regulate a gene-edited plant that has no foreign DNA as a genetically modified (GM) organism?

Jansson, who works at Umeรฅ University in Sweden, says that he will drop his experiments if the plants are classed as GM, because Europeโ€™s onerous regulations would make his work too expensive and slow. He and many others are anxiously awaiting the commissionโ€™s decision, which will dictate how they approach experiments using the latest gene-editing techniques, including theย popular CRISPRโ€“Cas9 method.

The commission has repeatedly stalled on delivering its verdict, which will apply to edited animals and microorganisms as well as plants. It now says that it will make its legal analysis public by the end of March. . .

Whatever the commission decides, it is likely that either a member state, an NGO or a company will sue โ€” meaning that the European Court of Justice may make the final, binding decision on the matter.

Read full, original post:ย  Europeโ€™s genetically edited plants stuck in legal limbo

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: โ€˜Safer for children?โ€™ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates โ€˜skyrocketingโ€™ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Foodโ€”health harming industries or life-saving innovators?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
png-pill-omega-Supp-fish-oil
Millions take omega-3 fish oil for brain health. New research suggests it may do the opposite.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.